Cigna, UnitedHealth and CVS Caremark are calling Federal Trade Commission (FTC) Chair Lina Khan and two other commissioners to either recuse themselves, or be removed from the agency’s lawsuit ...

FTC’s case against CVS, Cigna, and UnitedHealth’s PBMs is on hold for at least 105 days. An evidentiary hearing is scheduled 225 days after the stay is lifted. Today's manic market swings are ...

Cigna posts strong Q1 results with rising sales at Evernorth and Cigna Healthcare; raises 2025 EPS outlook to $29.60 amid ...

The FTC on Tuesday paused its in-house case against CVS Health’s CVS Caremark, Cigna’s Express Scripts and UnitedHealth Group’s OptumRx, which alleges the companies wrongly inflated insulin ...

CVS Health, Cigna and UnitedHealth Group have denied the FTC's allegations and have attempted to have the case dismissed. The FTC has also released reports over the past year that found the ...

The lawsuit – which has been anticipated since the FTC published a damning report on the PBM sector in July – names CVS Health's Caremark, UnitedHealth Group's Optum, and Cigna's Express ...

FILE PHOTO: A screen displays the logo fro Cigna Corp. on the floor at the NYSE in New York ...

Cigna has been in a holding pattern, posting a small loss of 1% while floating around $338.25. However, the stock is beating the S&P 500’s 6.9% decline during that period. The FTC says it doesn ...

CVS Health’s Caremark and Cigna’s Express Scripts, over insulin pricing practices is set to move forward after being paused last week. FTC chair Andrew Ferguson said April 3 that he would no ...

Last year, the Federal Trade Commission (FTC) caused consternation among pharmacy ... the big three players in the sector – CVS' Caremark, Cigna's Express Scripts, and UnitedHealth's OptumRx.

The FTC lawsuit accuses the PBMs of unfairly limiting ... told Reuters in a statement. UnitedHealth and Cigna did not immediately respond to Reuters' requests for comment. The three companies ...